ARTICLE | Financial News
Valeant Pharmaceuticals financial update
September 29, 2014 7:00 AM UTC
Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Laval, Quebec Business: Neurology, Dermatology Date announced: 2014-09-15 Note: Valeant plans to redeem all $500 million in outstanding ...